SLC6A3 and attention deficit-hyperactivity disorder: So far, we have shown that a single administration of CE-123, a novel DAT inhibitor, before testing attenuated locomotor hyperactivity (an ADHD-like symptom) in adolescent rats and reversed learning disabilities in adult rats exposed to ethanol over the neonatal period [35].